Literature DB >> 15638064

Inefficacy of etanercept in a child with hyper-IgD syndrome and periodic fever.

F Marchetti, E Barbi, A Tommasini, C Oretti, A Ventura.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15638064

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN： 0392-856X            Impact factor:   4.473


× No keyword cloud information.
  9 in total

Review 1.  Treatment of hyperimmunoglobulinemia D syndrome with biologics in children: review of the literature and Finnish experience.

Authors:  Svetlana Kostjukovits; Liisa Kalliokoski; Kaisu Antila; Matti Korppi
Journal:  Eur J Pediatr       Date:  2015-02-27       Impact factor: 3.183

2.  A patient with hyper-IgD syndrome responding to anti-TNF treatment.

Authors:  Erkan Demirkaya; M Kazim Caglar; Hans R Waterham; Rezan Topaloglu; Seza Ozen
Journal:  Clin Rheumatol       Date:  2006-12-15       Impact factor: 2.980

3.  A rare cause of AA amyloidosis and end-stage kidney failure: Answers.

Authors:  Mehmet Taşdemir; Sezen Yılmaz; Zeliha Füsun Baba; Ilmay Bilge
Journal:  Pediatr Nephrol       Date:  2018-11-19       Impact factor: 3.714

4.  Etanercept and anakinra can prolong febrile episodes in patients with hyperimmunoglobulin D and periodic fever syndrome.

Authors:  Hiba M Shendi; Deirdre Walsh; J David M Edgar
Journal:  Rheumatol Int       Date:  2009-12-18       Impact factor: 2.631

Review 5.  Fevers and the rheumatologist.

Authors:  Prudence Joan Manners; Robin Guttinger
Journal:  Indian J Pediatr       Date:  2010-10-16       Impact factor: 1.967

6.  Nummular keratopathy in a patient with Hyper-IgD Syndrome.

Authors:  Courtney L Kraus; Susan M Culican
Journal:  Pediatr Rheumatol Online J       Date:  2009-08-05       Impact factor: 3.054

Review 7.  Hereditary auto-inflammatory disorders and biologics.

Authors:  Leigh D Church; Sarah M Churchman; Philip N Hawkins; Michael F McDermott
Journal:  Springer Semin Immunopathol       Date:  2006-05-04

Review 8.  Autoinflammatory syndromes: diagnosis and management.

Authors:  Sara De Sanctis; Manuela Nozzi; Marianna Del Torto; Alessandra Scardapane; Stefania Gaspari; Giuseppina de Michele; Luciana Breda; Francesco Chiarelli
Journal:  Ital J Pediatr       Date:  2010-09-03       Impact factor: 2.638

Review 9.  The Central Role of Anti-IL-1 Blockade in the Treatment of Monogenic and Multi-Factorial Autoinflammatory Diseases.

Authors:  Silvia Federici; Alberto Martini; Marco Gattorno
Journal:  Front Immunol       Date:  2013-10-31       Impact factor: 7.561
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.